Full Breakdown
Genetic Insights into Substance Use Disorders
3/23/2026, 12:15:00 PM
Understanding Genetic Risk Pathways
A recent study led by Holly Poore from Rutgers Health has revealed that the majority of genetic risk for developing substance use disorders (SUDs) is linked to genes that influence how the brain processes rewards and regulates impulses, rather than genes specific to individual substances. The research, published in *Nature Mental Health*, analyzed genetic data from over 2.2 million individuals, focusing on alcohol, tobacco, cannabis, and opioid use disorders. The findings indicate that genetic predisposition operates through two primary pathways: a broad "behavioral disinhibition" pathway and substance-specific pathways.
The behavioral disinhibition pathway encompasses traits such as impulsivity and risk-taking, which are associated with various behavioral disorders, including attention-deficit/hyperactivity disorder (ADHD). This pathway is characterized by heritable patterns that cut across multiple forms of addiction. In contrast, substance-specific pathways are more narrowly focused on particular drugs, such as genes involved in alcohol metabolism or nicotine receptors.
Methodology and Findings
The researchers utilized advanced genomic methods to analyze the interplay between substance use disorders and related externalizing traits. By modeling these traits together, they identified hundreds of genetic variants linked to both broad externalizing liabilities and specific substances. Poore noted that traditional gene-finding efforts often focused on single disorders, but this study highlights the interconnected nature of substance use disorders.
The study also developed polygenic scores, which aggregate thousands of genetic variants into a single index of genetic liability. These scores have shown promise in predicting vulnerability to multiple substance use disorders, with broader scores indicating general risk and substance-specific scores providing insights into risks associated with particular drugs.
Implications for Treatment and Prevention
The findings of this study have significant implications for prevention and treatment strategies. According to Danielle Dick, director of the Rutgers Addiction Research Center, understanding genetic risk can help identify individuals who may benefit from targeted interventions. The research emphasizes that while genetic factors play a role, they do not determine an individual's fate regarding addiction.
Moreover, the study's authors conducted analyses that suggest potential biological systems and medications that could be repurposed for treatment. They highlighted the overlap of genes associated with the broad externalizing pathway and those implicated in other psychiatric disorders, underscoring the shared biological underpinnings of these conditions.
Limitations and Future Research
Despite the comprehensive nature of the study, the authors acknowledged limitations, particularly the focus on individuals of European ancestry due to the availability of large-scale genetic datasets. They stressed the need for more diverse genomic research to ensure that findings are applicable across different populations.
Conclusion
This study provides a nuanced understanding of the genetic roots linking substance use disorders with behavioral disinhibition. By elucidating both broad and specific genetic pathways, researchers aim to enhance prevention, intervention, and treatment strategies for addiction. The collaborative effort involved researchers from institutions including SUNY Downstate Health Sciences University, the University of California San Diego, and Harvard Medical School, among others.
Verbatim Quotes
“Addiction is incredibly complex, and this study shows just how important it is to look beyond any single substance or single gene,” — Holly Poore, Faculty Instructor of Psychiatry, Rutgers Robert Wood Johnson Medical School
“By understanding the common genetic roots that link substance use disorders with other forms of behavioral disinhibition – as well as the pathways that are specific to alcohol, nicotine, cannabis or opioids – we can build a more complete picture of vulnerability and ultimately support better prevention, intervention and treatment strategies.” — Danielle Dick, Director, Rutgers Addiction Research Center
